Literature DB >> 26601078

High T3, Low T4 Serum Levels in Mct8 Deficiency Are Not Caused by Increased Hepatic Conversion through Type I Deiodinase.

Eva K Wirth1, Eddy Rijntjes1, Franziska Meyer1, Josef Köhrle1, Ulrich Schweizer1.   

Abstract

BACKGROUND: The Allan-Herndon-Dudley syndrome is a severe psychomotor retardation accompanied by specific changes in circulating thyroid hormone levels (high T3, low T4). These are caused by mutations in the thyroid hormone transmembrane transport protein monocarboxylate transporter 8 (MCT8).
OBJECTIVE: To test the hypothesis that circulating low T4 and high T3 levels are caused by enhanced conversion of T4 via increased activity of hepatic type I deiodinase (Dio1).
METHODS: We crossed mice deficient in Mct8 with mice lacking Dio1 activity in hepatocytes. Translation of the selenoenzyme Dio1 was abrogated by hepatocyte-specific inactivation of selenoprotein biosynthesis.
RESULTS: Inactivation of Dio1 activity in the livers of global Mct8-deficient mice does not restore normal circulating thyroid hormone levels.
CONCLUSIONS: Our data suggest that although hepatic Dio1 activity is increased in Mct8-deficient mice, it does not cause the observed abnormal circulating thyroid hormone levels. Since global inactivation of Dio1 in Mct8-deficient mice does normalize circulating thyroid hormone levels, the underlying mechanism and relevant tissues involved remain to be elucidated.

Entities:  

Keywords:  Allan-Herndon-Dudley syndrome; Deiodinase; Slc16a2; Thyroid hormone; Type I deiodinase

Year:  2015        PMID: 26601078      PMCID: PMC4640264          DOI: 10.1159/000381021

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  17 in total

1.  Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum T3 levels.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Honggang Ye; Alfonso Massimiliano Ferrara; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

2.  Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice.

Authors:  Florian Streckfuss; Inka Hamann; Lutz Schomburg; Marten Michaelis; Remy Sapin; Marc O Klein; Josef Köhrle; Ulrich Schweizer
Journal:  Biochem Biophys Res Commun       Date:  2005-09-26       Impact factor: 3.575

3.  Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Alexandra M Dumitrescu; Nancy J Philp; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

4.  Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice.

Authors:  Marija Trajkovic-Arsic; Julia Müller; Veerle M Darras; Claudia Groba; Sooyeon Lee; Debra Weih; Karl Bauer; Theo J Visser; Heike Heuer
Journal:  Endocrinology       Date:  2010-08-11       Impact factor: 4.736

5.  Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.

Authors:  Alexandra M Dumitrescu; Xiao-Hui Liao; Roy E Weiss; Kathleen Millen; Samuel Refetoff
Journal:  Endocrinology       Date:  2006-05-18       Impact factor: 4.736

6.  Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice.

Authors:  Mark J Schneider; Steven N Fiering; B Thai; Sing-yung Wu; Emily St Germain; Albert F Parlow; Donald L St Germain; Valerie Anne Galton
Journal:  Endocrinology       Date:  2005-10-13       Impact factor: 4.736

7.  Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.

Authors:  Marija Trajkovic; Theo J Visser; Jens Mittag; Sigrun Horn; Jan Lukas; Veerle M Darras; Genadij Raivich; Karl Bauer; Heike Heuer
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

8.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.

Authors:  Edith C H Friesema; Annette Grueters; Heike Biebermann; Heiko Krude; Arpad von Moers; Maarten Reeser; Timothy G Barrett; Edna E Mancilla; Johan Svensson; Monique H A Kester; George G J M Kuiper; Sahila Balkassmi; André G Uitterlinden; Josef Koehrle; Patrice Rodien; Andrew P Halestrap; Theo J Visser
Journal:  Lancet       Date:  2004 Oct 16-22       Impact factor: 79.321

9.  Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome.

Authors:  Eva K Wirth; Stephan Roth; Cristiane Blechschmidt; Sabine M Hölter; Lore Becker; Ildiko Racz; Andreas Zimmer; Thomas Klopstock; Valerie Gailus-Durner; Helmut Fuchs; Wolfgang Wurst; Thomas Naumann; Anja Bräuer; Martin Hrabé de Angelis; Josef Köhrle; Annette Grüters; Ulrich Schweizer
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

10.  Secisbp2 is essential for embryonic development and enhances selenoprotein expression.

Authors:  Sandra Seeher; Tarik Atassi; Yassin Mahdi; Bradley A Carlson; Doreen Braun; Eva K Wirth; Marc O Klein; Nathalie Reix; Angela C Miniard; Lutz Schomburg; Dolph L Hatfield; Donna M Driscoll; Ulrich Schweizer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

View more
  4 in total

Review 1.  New insights into thyroid hormone action.

Authors:  Arturo Mendoza; Anthony N Hollenberg
Journal:  Pharmacol Ther       Date:  2017-02-04       Impact factor: 12.310

2.  The relationship between inflammatory factors, oxidative stress and DIO-1 concentration in patients with chronic renal failure accompanied with or without euthyroid sick syndrome.

Authors:  Shu-Lan Qin; Qi He; Ling Hu; Chun-Yan He; Li-Cheng Gao; Charlotte Aimee Young; Juan Chen; Cheng-Fang Jiang; Xiang-Feng Luo; Ying Zhou; Xia Sheng; Zhi-Hong Li; Mei-Ling Chen; Gaosi Xu
Journal:  J Int Med Res       Date:  2018-08-28       Impact factor: 1.671

Review 3.  Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.

Authors:  Ferdy S van Geest; Nilhan Gunhanlar; Stefan Groeneweg; W Edward Visser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

4.  Canonical TSH Regulation of Cathepsin-Mediated Thyroglobulin Processing in the Thyroid Gland of Male Mice Requires Taar1 Expression.

Authors:  Maria Qatato; Joanna Szumska; Vladislav Skripnik; Eddy Rijntjes; Josef Köhrle; Klaudia Brix
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.